Investigational once-weekly retatrutide yielded the greatest weight loss of all GLP-1 receptor agonists, up to 22.1% after 48 ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

For this review, the authors searched for randomized controlled trials published in MEDLINE, Embase, and Cochrane CENTRAL ...

LifeVantage's new MindBody GLP-1 System is riding the coattails of GLP-1 weight loss drugs. See why I rate LFVN stock as a ...

For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious ...

Drug manufacturers soon developed offerings of the drug that are expressly approved for use in weight loss. It may seem like everyone is taking a GLP-1 agonist these days, but individuals who are ...

What does the latest science say about the use of GLP-1 meds to treat obesity in people without diabetes?A review of 26 ...

Topline data were announced from a phase 3 trial evaluating CagriSema in overweight or obese patients without type 2 diabetes.

medications known as glucagon-like peptide-1 agonists, or GLP-1s, have become very popular as weight loss treatments. Taken in accordance with instructions on the label and an appropriate diet and ...

On the surface, the formula for weight ... lose weight and keep it off, it’s a welcome and helpful development. Though we are now seeing several new iterations of the class of drugs known ...

(MENAFN- The Conversation) On the surface, the formula for weight loss seems simple ... drugs known scientifically as Glucagon-like peptide 1 receptor (GLP-1R) agonists (you may know them under ...

Study: Suicide and suicide attempt in users of GLP-1 receptor agonists: a nationwide case ... GLP-1 RAs are used for treating type 2 diabetes and weight loss by regulating insulin secretion ...